Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis

NDT Plus

Volumn 3, Issue 2, 2010, Pages 132-134

  Aravindan, Ananthakrishnapuram ^a   Yong, Jim ^a   Killingsworth, Murray ^a   Suranyi, Michael ^a   Wong, Jeffrey ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

interferon beta; minimal change disease; nephrotic syndrome; relapsing remitting multiple sclerosis

Indexed keywords

ATORVASTATIN; BETA1A INTERFERON; CHOLESTEROL; CREATININE; METHYLPREDNISOLONE; PREDNISONE; RAMIPRIL; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; DISEASE DURATION; DRUG WITHDRAWAL; ELECTROPHORESIS; ERYTHROCYTE; FEMALE; FOOT EDEMA; HUMAN; IMMUNOELECTROPHORESIS; INTERMITTENT CATHETERIZATION; KIDNEY BIOPSY; LEG; MICROSCOPY; MULTIPLE SCLEROSIS; NEPHROTIC SYNDROME; NEUROGENIC BLADDER; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SPASTICITY; URINALYSIS;

EID: 77955962292     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp162     Document Type: Article

References (10)

1. WaltherEU, Hohlfeld R. Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 1999; 53: 1622-1627
2. Averbuch SD, Austin HA 3rd, Sherwin SA et al. Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides. N Engl J Med 1984; 310:32-35
3. Magee CC. Renal thrombotic microangiopathy induced by interferon- alpha. Nephrol Dial Transplant 2001; 16: 2111-2112
4. Bremer CT, Lastrapes A, Alper AB Jr et al. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature. Am J Clin Oncol 2003; 26: 262-264
5. Gotsman I, Elhallel-Darnitski M, FriedlanderZ et al. Beta-interferon- induced nephrotic syndrome in a patient with multiple sclerosis. Clin Nephrol 2000; 54: 425-426
6. Tola MR, Caniatti LM, Gragnaniello D et al. Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1a. J Neurol 2003; 250: 768-769
7. Auty A, Saleh A. Nephrotic syndrome in a multiple sclerosis patient treated with interferon beta 1a. Can J Neurol Sci 2005; 32: 366-368
8. Kumasaka R, Nakamura N, Shirato K et al. Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis. Clin Exp Nephrol 2006; 10:222-225
9. Nishimura S, Miura H, Yamada H et al. Acute onset of nephrotic syndrome during interferon-alpha retreatment for chronic active hepatitis c. J Gastroenterol 2002; 37: 854-858
10. Emsley HC, Molloy J. Inflammatory demyelinating polyradiculoneu- ropathy associated with membranous glomerulonephritis and throm- bocytopaenia. Clin Neurol Neurosurg 2002; 105: 23-26